{
    "2018-11-20": [
        [
            {
                "time": "2018-11-01",
                "original_text": "AbbVie (ABBV) Stock Moves -1.55%: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "stock moves",
                        "-1.55%",
                        "know"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "3 Top Large-Cap Stocks to Buy in November",
                "features": {
                    "keywords": [
                        "top",
                        "large-cap",
                        "stocks",
                        "buy",
                        "November"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Why Has AstraZenecaâ€™s Stock Price Increased in 2018?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "stock price",
                        "increased",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "SHAREHOLDER ALERT: ABBV JT CWH HON DY RYAAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "ALERT",
                        "ABBV",
                        "class action",
                        "deadlines"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "DEADLINE",
                        "TODAY",
                        "Schall Law Firm",
                        "class action lawsuit",
                        "AbbVie Inc.",
                        "losses"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018",
                "features": {
                    "keywords": [
                        "FINAL",
                        "DEADLINE",
                        "ALERT",
                        "Bronstein",
                        "Gewirtz",
                        "&",
                        "Grossman,",
                        "LLC",
                        "class action",
                        "AbbVie Inc.",
                        "lead plaintiff deadline"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "AbbVie to Highlight Breadth of Innovative Science and Ongoing Commitment to Blood Cancer Patients with New Data From Studies of Ibrutinib and Venetoclax at 2018 American Society of Hematology Annual Meeting & Exposition",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "innovative science",
                        "blood cancer",
                        "patients",
                        "data",
                        "ibrutinib",
                        "venetoclax",
                        "American Society of Hematology",
                        "Annual Meeting",
                        "Exposition"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Today's Research Reports on Trending Tickers: AstraZeneca and AbbVie",
                "features": {
                    "keywords": [
                        "Today's",
                        "Research Reports",
                        "Trending Tickers",
                        "AstraZeneca",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}